Expert interventionalists, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) discuss the most anticipated hot line studies to be unveiled at ESC Congress 2025. Tune in for their in-depth analysis to get ahead of the curve.

ESC Congress 2025 Hot Line Trials Discussed:

DOUBLE CHOICE

VANTAGE

OPTION-STEMI

DUAL-ACS

NEO MINDSET

TARGET-FIRST

FIRE

AI GATEKEEPER

LAAC Closure

Stay tuned for Radcliffe Cardiology’s in-depth coverage of these and other pivotal trials from ESC Congress 2025.